BioCentury
ARTICLE | Clinical News

Neuradiab: Phase III delayed

February 23, 2009 8:00 AM UTC

Bradmer said slow enrollment due to slow site initiation in the ongoing Phase III GLASS-ART trial of Neuradiab has prompted the company to evaluate strategic alternatives after the delay meant it woul...